Research Article
Open access
Published on 29 April 2024
Download pdf
Wang,Z.;Bai,Y.;Li,S.;Dong,M.;Sun,S.;Gou,Y.;Chen,W.;Zhang,X. (2024). Efficacy and Mechanism of Fuyang Yiyin Method in Pulmonary Fibrosis Based on the Theory of “Yang Transforming into Qi, Yin Constituting Form”. Journal of Clinical Technology and Theory,1,6-12.
Export citation

Efficacy and Mechanism of Fuyang Yiyin Method in Pulmonary Fibrosis Based on the Theory of “Yang Transforming into Qi, Yin Constituting Form”

Zihan Wang 1, Yuejie Bai 2, Shuang Li 3, Meng Dong 4, Shengjun Sun 5, Yuxiao Gou 6, Wenjie Chen 7, Xinyue Zhang *,8,
  • 1 Shandong University of Traditional Chinese Medicine
  • 2 Shandong University of Traditional Chinese Medicine
  • 3 Shandong University of Traditional Chinese Medicine
  • 4 Shandong University of Traditional Chinese Medicine
  • 5 Shandong University of Traditional Chinese Medicine
  • 6 Shandong University of Traditional Chinese Medicine
  • 7 Shandong University of Traditional Chinese Medicine
  • 8 Affiliated Hospital of Shandong University of Traditional Chinese Medicine

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/3049-5458/1/2024002

Abstract

Idiopathic pulmonary fibrosis (IPF) is a common pathological manifestation of various pulmonary diseases, characterized by insidious onset and progression to irreversible organ failure. Currently, there are still inadequacies in the diagnosis and treatment of IPF. Traditional Chinese medicine (TCM) can intervene in IPF at multiple levels, targets, and pathways, possessing significant advantages in the treatment of IPF. The underlying mechanisms deserve further exploration. The theory of “Yang Transforming into Qi, Yin Constituting Form” in Huangdi Neijing embodies the specific meanings of yin and yang, containing profound views on life and disease. The pathological changes of IPF conform to the theory of yin and yang in “Yang Transforming into Qi, Yin Constituting Form”, where deficiency of yang transforming into qi and excessive formation of yin constitute the core pathogenesis of IPF. This paper proposes the principle of Fuyang Yiyin for IPF, aiming to nourish the source of fire and dispel yin turbidity, in order to broaden the clinical treatment strategies for IPF.

Keywords

Yang transforming into Qi, Yin constituting form, pulmonary fibrosis, Fuyang, Yiyin

[1]. LEóN-ROMáN, F., VALENZUELA, C., & MOLINA-MOLINA, M. (2022). Idiopathic pulmonary fibrosis. Medicina Clinica, 159(4), 189-194.

[2]. AMARAL, A. F., COLARES, P. D. B., & KAIRALLA, R. A. (2023). Idiopathic pulmonary fibrosis: current diagnosis and treatment. Jornal Brasileiro De Pneumologia, 49(4).

[3]. BLEINC, A., BLIN, T., LEGUE, S., et al. (2023). Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication. Revue Des Maladies Respiratoires, 40(5), 371-381.

[4]. MACKINTOSH, J. A., KEIR, G., TROY, L. K., et al. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology, 29(2), 105-135.

[5]. WANG, G., YANG, J., & WANG, Z. (2018). Research progress of traditional Chinese medicine treatment for idiopathic interstitial pneumonia. Xin Zhong Yi, 50(05), 215-218.

[6]. LI, X., CHANG, H., SHI, S. L., et al. (2021). Research progress on the pathogenesis and traditional Chinese medicine treatment of pulmonary fibrosis. Zhong Yao Yao Li Yu Lin Chuang, 37(01), 240-247.

[7]. XU, B. W., LI, J., GAO, R. K., et al. (2020). Discussion on the diagnosis and treatment of tumors based on the theory of “Yang Transformation into Qi, Yin Constituting Form”. Zhong Yi Za Zhi, 61(04), 315-318.

[8]. ZHANG, X. Y., RAO, Y. D., GUO, C. X., et al. (2020). Discussion on the meaning of “Yang Transformation into Qi, Yin Constituting Form” in Neijing. Liaoning Zhong Yi Za Zhi, 47(04), 80-82.

[9]. KONG, J. Y., & ZHU, H. Y. (2021). Discussion on the application of peony “tonifying Qi” effect in prescriptions based on the concept of “Yin Qi”. Zhong Guo Min Zu Min Jian Yi Yao, 30(20), 1-4.

[10]. GUO, S. J., FENG, J. H., SONG, Y. L., et al. (2018). Preliminary study on the evolution law of TCM syndrome elements in different stages of idiopathic pulmonary fibrosis. Shi Jie Zhong Xi Yi Jie He Za Zhi, 13(06), 809-812+65.

[11]. YU, J. W., XUE, H. R., ZHANG, Y. B., et al. (2015). Collection of academic thoughts on diagnosis and treatment of pulmonary diseases by national master of traditional Chinese medicine Hong Guangxiang. Zhong Hua Zhong Yi Yao Za Zhi, 30(11), 3824-3829.

[12]. YANG, Y., & YANG, Y. P. (2021). One case of idiopathic pulmonary fibrosis treated by Yang Yuping. Hu Nan Zhong Yi Za Zhi, 37(11), 92-93.

[13]. ZHANG, Y. F., & ZHAO, J. X. (2020). Discussion on the diagnosis and treatment of pulmonary interstitial fibrosis from the perspective of Zhao Jinxi’s syndrome differentiation and treatment. Zhong Yi Xue Bao, 35(09), 1934-1938.

[14]. LAN, Z. H., ZHANG, Y. B., LI, S. F., et al. (2014). Experience of Professor Liu Liangdi in treating pulmonary interstitial fibrosis with WENLUOHUAXIAN Formula. Zhong Hua Zhong Yi Yao Za Zhi, 29(10), 3141-3143.

[15]. ZHANG, F. L., & TAO, H. H. (2011). Discussion on the diagnosis and treatment rules of lung yang deficiency syndrome from Jin Gui Yao Lue. Shan Dong Zhong Yi Yao Da Xue Xue Bao, 35(06), 500-501.

[16]. ZHANG, Q., & ZHANG, W. (2023). Discussion on the theory of “Yang Transformation into Qi and Yin Constituting Form” in the treatment of idiopathic pulmonary fibrosis in traditional Chinese medicine. Guang Ming Zhong Yi, 38(09), 1653-1655.

[17]. YUAN, C. B., WANG, T., & SHI, L. (2014). Modified Xiao Qing Long Decoction in the treatment of pulmonary interstitial fibrosis. Journal of Changchun University of Traditional Chinese Medicine, 30(04), 640-641+4.

[18]. HE, S. F., WANG, X. H., CHEN, X. R., et al. (2023). Relationship between mitochondrial dysfunction and pelvic organ prolapse based on the “spleen-mitochondria correlation” theory. Zhong Guo Min Zu Min Jian Yi Yao, 32(17), 13-17.

[19]. ZHENG, M. L. (2004). Substantive cell biology hypothesis of Tibetan medicine. Zhong Yi Yao Xue Kan, (06), 1068-1070.

[20]. RANGARAJAN, S., BERNARD, K., & THANNICKAL, V. J. (2017). Mitochondrial Dysfunction in Pulmonary Fibrosis. Annals of the American Thoracic Society, 14, S383-S388.

[21]. LU, Z. K., & HUANG, Y. Q. (2022). Scientific connotation of “Yang Transformation into Qi and Yin Constituting Form” based on endoplasmic reticulum function. Zhong Hua Zhong Yi Yao Xue Kan, 40(09), 149-151.

[22]. RAGHU, G. (2019). Idiopathic pulmonary fibrosis: shifting the concept to irreversible pulmonary fibrosis of many entities. Lancet Respiratory Medicine, 7(11), 926-929.

[23]. THEOCHARIS, A. D., SKANDALIS, S. S., GIALELI, C., et al. (2016). Extracellular matrix structure. Advanced Drug Delivery Reviews, 97, 4-27.

[24]. YE, W., SUN, M. Y., & WANG, X. H. (2020). Research progress on the relationship between idiopathic pulmonary fibrosis and the cellular microenvironment. Journal of Chinese Academy of Medical Sciences, 42(03), 410-416.

[25]. XIAO, F. (2019). The philosophical bridge between traditional Chinese medicine and modern medicine. Zhong Guo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu, 17(14), 22-28.

[26]. ZHAO, F. D., & CAI, C. L. (1993). Application of Hong Guangxiang’s “treatment of lungs without being far away” in chronic cough and asthma. Jiangxi Zhong Yi Yao, (02), 3-4.

[27]. LAN, Z. H., ZHANG, Y. B., ZHU, W., et al. (2012). Clinical experience of treating pulmonary interstitial fibrosis with the whole-process warming method. Zhong Yi Yao Tong Bao, 11(05), 38-40.

[28]. ZHANG, H. M., DING, H., & CHEN, R. (2015). Experience in treating pulmonary fibrosis with warming yang, dispelling cold, and promoting meridian circulation method. Zhong Guo Zhong Yi Yao Xin Xi Za Zhi, 22(04), 100-101.

[29]. LI, K., WANG, Q., DUAN, P. P., et al. (2023). Mechanism of warming yang and dissolving turbidity and promoting blood circulation formula in inhibiting systemic sclerosis EndoMT. Journal of Nanyang Institute of Technology, 15(06), 118-122+28.

[30]. WANG, Y. Y. (2023). Clinical observation of warming yang and promoting blood circulation method in treating idiopathic pulmonary fibrosis and experimental study on improving pulmonary fibrosis by regulating oxidative stress and iron death [Doctoral dissertation, Shandong University of Traditional Chinese Medicine].

[31]. LI, F. R. (2023). Mechanism of hepatocyte growth factor (HGF) regulating TGF-β1/Smads signaling pathway intervention in epithelial-mesenchymal transition (EMT) of pulmonary fibrosis rats based on replenishing Qi, warming Yang, and promoting meridian circulation method [Doctoral dissertation, Shandong University of Traditional Chinese Medicine].

[32]. SU, J., & ZHANG, W. (2021). Discussion on the pathogenesis and treatment of idiopathic pulmonary fibrosis based on the theory of lung collaterals obstruction and accumulation and dispersion. Zhong Yi Za Zhi, 62(11), 947-950+70.

[33]. LI, M. Y., LIU, H. Y., CHEN, C. B., et al. (2021). Diagnosis and treatment of pulmonary obstruction. Rheumatism and Arthritis, 10(01), 54-57.

[34]. CHENG, Y. N., & SHI, S. F. (2012). Professor Shi Suofang’s experience in treating pulmonary obstruction with open draining and dispersing obstruction method. Journal of Jilin Traditional Chinese Medicine, 32(05), 450-451.

[35]. ZHANG, R. J., & CHEN, W. (2019). Experience of Director Chen Wei in diagnosing and treating idiopathic pulmonary fibrosis from the perspectives of deficiency, phlegm, and blood stasis. Journal of Shaanxi University of Chinese Medicine, 42(06), 60-62+74.

[36]. WANG, Z. X., & ZHANG, W. (2017). Discussion on the treatment of idiopathic pulmonary fibrosis based on the theory of “lung Qi and Yin deficiency, phlegm and stasis lurking in collaterals”. Journal of Changchun University of Traditional Chinese Medicine, 33(03), 386-389.

[37]. YU, R. Z., PANG, L. J., WANG, T. J., et al. (2022). Diagnosis and treatment of idiopathic pulmonary fibrosis based on deficiency, toxin, phlegm, and blood stasis. Zhong Hua Zhong Yi Yao Za Zhi, 37(10), 5815-5818.

Cite this article

Wang,Z.;Bai,Y.;Li,S.;Dong,M.;Sun,S.;Gou,Y.;Chen,W.;Zhang,X. (2024). Efficacy and Mechanism of Fuyang Yiyin Method in Pulmonary Fibrosis Based on the Theory of “Yang Transforming into Qi, Yin Constituting Form”. Journal of Clinical Technology and Theory,1,6-12.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Journal:Journal of Clinical Technology and Theory

Volume number: Vol.1
ISSN:3049-5458(Print) / 3049-5466(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).